Featured News

  • FDA expands coronavirus testing capacity with support of commercial labs

    February 29, 2020
    WASHINGTON, D.C. – ACLA is currently reviewing the FDA’s guidance for high complexity, CLIA-certified laboratories (which includes hospital, academic, and commercial laboratories) to provide coronavirus testing in advance of Emergency Use Authorization (EUA).  The guidance permits high complexity laboratories to start offering coronavirus testing as soon as validation is complete.  The FDA recommends that a laboratory submit the EUA request to the agency fifteen businessContinue Reading »...
  • Update on COVID-19 Outbreak

    February 28, 2020
    Commercial Labs Working Closely with Public Health Partners, Stand Ready To Support Increased Test Capacity If Needed WASHINGTON, D.C. —  In response to the latest developments and spread of the COVID-19 in the United States, ACLA President Julie Khani released the following statement: “As part of our commitment to supporting the emergency preparedness and public health of the United States, commercial laboratories are readyContinue Reading »...
  • ACLA Announces Key Staff Promotions

    January 09, 2020
    WASHINGTON, D.C.—The American Clinical Laboratory Association (ACLA) today announced the promotions of Thomas Sparkman to Senior Vice President of Government Affairs and Policy, and Andrew Young to Senior Coordinator. “Over the past seven years, Tom has been instrumental in advancing ACLA’s key priorities in front of Congress and the Administration, including recent passage of the Laboratory Access for Beneficiaries (LAB) Act,” said Julie Khani,Continue Reading »...
  • Congress Passes The LAB Act, Paving The Way For Future PAMA Reform

    December 19, 2019
    As seniors brace for a new set of cuts to clinical lab services in January, Congress takes decisive action to halt faulty data collection process responsible for year-over-year cuts to Medicare lab benefits – Independent study will assess how to improve data reporting under PAMA   WASHINGTON, D.C. – In a victory for 53 million seniors who depend on clinical laboratory diagnostics for theirContinue Reading »...
  • ACLA Announces 60 Minutes Correspondent and Author Scott Pelley as Keynote Speaker for 2020 Annual Meeting  

    December 16, 2019
    WASHINGTON, D.C. – The American Clinical Laboratory Association (ACLA) today announced that Scott Pelley, 60 Minutes correspondent and former anchor and managing editor of the CBS Evening News, will deliver the keynote address during the association’s Annual Meeting on March 4, 2020. Pelley, a legendary storyteller who recently published a memoir, Truth Worth Telling, will share reflections on his career and provide insight onContinue Reading »...
  • ACLA Applauds Introduction of the LAB Act in the Senate

    December 13, 2019
    WASHINGTON, D.C. – Ahead of a crucial deadline to safeguard seniors’ access to lifesaving clinical laboratory services, Sen. Richard Burr (R-NC) and Sen. Sherrod Brown (D-OH) introduced the Laboratory Access for Beneficiaries (LAB) Act, bipartisan legislation to address critical data collection deficiencies resulting in year-over-year cuts to Medicare lab benefits.   Like its counterpart in the House of Representatives (H.R. 3584), the Senate billContinue Reading »...
  • ACLA Outlines Key Changes Required to Protect Beneficiaries’ Access to Cancer Testing

    December 03, 2019
    WASHINGTON, D.C. – Recent proposals from the Centers for Medicare & Medicaid Services (CMS) would have widespread, detrimental consequences on cancer care for millions of Medicare beneficiaries, specifically for patients with a genetic predisposition for breast and ovarian cancer. In new comments submitted to the agency, the American Clinical Laboratory Association (ACLA) called on CMS to remove barriers to coverage of germline tests usingContinue Reading »...
  • As Seniors’ Lab Benefits Hang In The Balance, Leading Stakeholder Groups Urge Congress To Pass LAB Act In End-of-Year Legislation

    December 03, 2019
    WASHINGTON, D.C.— In a new letter to Congressional leadership, more than 33 stakeholder groups are urging lawmakers to pass commonsense, bipartisan reforms that would take steps to mitigate the ongoing harm facing more than 53 million seniors who depend on vital clinical laboratory services. The letter reinforces the urgent need for Congress to immediately advance H.R. 3584 – The Laboratory Access for Beneficiaries (LAB)Continue Reading »...
  • ACLA Comments on NGS Proposed Decision Memo

    November 26, 2019
    ...
  • ACLA Files A Motion for Summary Judgment Against HHS In ACLA v. Azar

    October 15, 2019
    Washington, D.C. — Following a favorable decision on a jurisdictional question issued by the U.S. Court of Appeals for the D.C. Circuit, the American Clinical Laboratory Association (ACLA) has filed a motion for summary judgment before the U.S. District Court for the District of Columbia challenging the flawed implementation of the Protecting Access to Medicare Act (PAMA) in the final rule promulgated by the U.S. DepartmentContinue Reading »...